2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$102.67-$0.02 (-0.02%)
Price as of Sep 11, 2026 7:30 PM EDT- $4.7BMarket Cap
- 96.72%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$102.67-$0.02 (-0.02%)
Earnings Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 16.05% | ||
12-Month Momentum | 70.79% | ||
3-Month Risk Adjusted Momentum | 115.00% | ||
12-Month Risk Adjusted Momentum | 152.41% |
True Yield
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.56% | ||
Net Debt Paydown Yield | 1.66% |
Financial Health Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |